Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
Amodiaquine + VR-776
|
DC8XYX9
|
Amodiaquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Arfolitixorin + VR-776
|
DC8D5ED
|
Arfolitixorin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Artemisinin + VR-776
|
DCA2JZ1
|
Artemisinin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BIO-300 + VR-776
|
DCKJB7P
|
BIO-300
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Bortezomib + VR-776
|
DCSKO89
|
Bortezomib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Diazoxide + VR-776
|
DCIJMZ6
|
Diazoxide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Doxorubicin + VR-776
|
DCDZ9V8
|
Doxorubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Endoxifen + VR-776
|
DCAT8BC
|
Endoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Epinephrine + VR-776
|
DCM4XNX
|
Epinephrine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Eptifibatide + VR-776
|
DCIFXMF
|
Eptifibatide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Gefitinib + VR-776
|
DC6J8O4
|
Gefitinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Hyodeoxycholic acid + VR-776
|
DCITPZK
|
Hyodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
JZL195 + VR-776
|
DCHQ61J
|
JZL195
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Maprotiline + VR-776
|
DCZ0BR3
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Maraviroc + VR-776
|
DCENQ5M
|
Maraviroc
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Meclofenamic acid + VR-776
|
DCTSVE6
|
Meclofenamic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Metaxalone + VR-776
|
DCIM3KL
|
Metaxalone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Methylene blue + VR-776
|
DCNDME4
|
Methylene blue
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Metyrosine + VR-776
|
DC5G4VK
|
Metyrosine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
NITD609 + VR-776
|
DCH6L28
|
NITD609
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Pepstatin + VR-776
|
DCNCIGP
|
Pepstatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
PMID28460551-Compound-2 + VR-776
|
DCJD0B6
|
PMID28460551-Compound-2
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Pyrazinamide + VR-776
|
DCCMWB2
|
Pyrazinamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Terameprocol + VR-776
|
DC7JCY2
|
Terameprocol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Teriflunomide + VR-776
|
DCX2MIO
|
Teriflunomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Tiagabine + VR-776
|
DCI9VDL
|
Tiagabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Tolazoline + VR-776
|
DC3KXBV
|
Tolazoline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Topotecan + VR-776
|
DCR7V6R
|
Topotecan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Vinblastine + VR-776
|
DCR4WMV
|
Vinblastine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Vorinostat + VR-776
|
DC92EGU
|
Vorinostat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Ribavirin-TP
|
DCCSX33
|
Ribavirin-TP
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Sertraline
|
DC2C3GU
|
Sertraline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Triiodothyronine
|
DC3VWSL
|
Triiodothyronine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Lumefantrine
|
DC2E2JK
|
Lumefantrine
|
DD2 (Cell Line: DD2)
|
[2] |
VR-776 + Triapine
|
DC1X5Y5
|
Triapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Emetine
|
DCLTJMU
|
Emetine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Chlorzoxazone
|
DC7JUDH
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Galantamine
|
DC18EWA
|
Galantamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Pazopanib
|
DCJB0ZS
|
Pazopanib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Daidzin
|
DCNL4LC
|
Daidzin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Zaleplon
|
DCGJFJ2
|
Zaleplon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Diphenidol
|
DCL0QF4
|
Diphenidol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Sulfapyridine
|
DCWCVP7
|
Sulfapyridine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Trazodone
|
DCT1OI7
|
Trazodone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Isoproterenol
|
DC5LGD1
|
Isoproterenol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Oseltamivir
|
DCZIT6V
|
Oseltamivir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Fenoprofen
|
DCYP5HZ
|
Fenoprofen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Idarubicin
|
DC06MY1
|
Idarubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Imatinib
|
DCOMCNM
|
Imatinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Mesalazine
|
DCX9CQ6
|
Mesalazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Clascoterone
|
DCBECY6
|
Clascoterone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Trimethobenzamide
|
DCFIHK8
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Maprotiline
|
DC1IC2W
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Leflunomide
|
DCHA9A2
|
Leflunomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Theophylline
|
DCEW4F8
|
Theophylline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Acarbose
|
DCUJ7XI
|
Acarbose
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Mycophenolic acid
|
DCQO04P
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Hydralazine
|
DCAGL6X
|
Hydralazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Pyronaridine
|
DCFYHFL
|
Pyronaridine
|
DD2 (Cell Line: DD2)
|
[2] |
VR-776 + Cytarabine
|
DC1E0G9
|
Cytarabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
VR-776 + Ruxolitinib
|
DCQ3XA7
|
Ruxolitinib
|
Hodgkin lymphoma (Cell Line: L-1236)
|
[3] |
WAY-100635 + VR-776
|
DCWBNBI
|
WAY-100635
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|